Brief: Cosmo: successful outcome of phase III clinical trial for Rifamycin SV MMX

Cosmo Electronics

06/06/2016 06:01

June 6 (Reuters) - Cosmo Pharmaceuticals SA  COPN.S : 
    * Cosmo announces successful outcome of phase III clinical trial for Rifamycin SV MMX 
 
Source text for Eikon:  ID:nTEN9s84ra  
Further company coverage:  COPN.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))